title: Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.
authors.forename: Caterina P
authors.initials: CP
authors.lastname: Minniti
authors.forename: Jonathan
authors.initials: J
authors.lastname: Wilson
authors.forename: Laurel
authors.initials: L
authors.lastname: Mendelsohn
authors.forename: Greg C
authors.initials: GC
authors.lastname: Rigdon
authors.forename: Jonathan W
authors.initials: JW
authors.lastname: Stocker
authors.forename: Alan T
authors.initials: AT
authors.lastname: Remaley
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Kato
mesh_terms: D000081:Acetamides / Q000627:therapeutic use*; D000328:Adult; D000755:Anemia, Sickle Cell / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010446:Peptide Fragments / Q000097:blood*; D014320:Triphenylmethyl Compounds / Q000627:therapeutic use*
chemical_list: D000081:Acetamides; D010446:Peptide Fragments; D014320:Triphenylmethyl Compounds; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain; C472774:senicapoc